Polycythemia vera: Diagnosis and treatment 2002

Expert Review of Anticancer Therapy

Volumn 2, Issue 3, 2002, Pages 330-336

  Berlin, Nathaniel I ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Acute leukemia; Blood volume; Hydroxyurea; Interferon; Myeloid metaplasia; Phlebotomy; Pipobroman (vercyte); Polycythemia vera diagnosis and treatment; Radioactive phosphorus

Indexed keywords

ACETYLPHENYLHYDRAZINE; ACETYLSALICYLIC ACID; ARSENIC TRIOXIDE; BUSULFAN; CHLORAMBUCIL; HYDROXYUREA; INTERFERON; PHENYLHYDRAZINE; PHOSPHORUS 32; PIPOBROMAN;

ACNE; ACUTE LEUKEMIA; ARTICLE; BLEEDING; BLOOD ANALYSIS; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG TOLERABILITY; DRY SKIN; FEMALE; HEMATOLOGY; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; POLYCYTHEMIA VERA; RADIOISOTOPE THERAPY; STOMATITIS; SYMPTOMATOLOGY; THROMBOSIS;

EID: 0036087818     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.2.3.330     Document Type: Article

References (46)

1. Chronic cyanosis with polycythemia and enlarged spleen: A new clinical entity
2. Relative polycythemia-the polycythemia of stress
3. The nature and treatment of polycythemia
4. Polycythemia I. Clinical and laboratory manifestations
5. The treatment of polycythemia Vera with radioactive phosphorus
6. Polycythemia vera and its treatment with radioactive phosphorus
7. Complications and causes of death in polycythemia vera
8. Polycythemia vera - Course and prognosis
9. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders
10. Contrasting Incidence of Acute monocytic and granulocytic leukemias in P32 treated patients with polycythemia vera and chronic lymphocytic leukemia
11. Polycythemia vera and leukemia - The role of radiation treatment
12. Therapeutic Recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols
13. Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years
14. 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age
15. Polycythemia vera: Clinical studies on a series of 127 patients managed without radiation therapy
16. From efficacy to safety: A Polycythemia Vera Study Group report on hydroxyurea in patients with polycythemia vera
17. The diagnosis and classification of the polycythemias
18. Classification of the polycythemias and initial clinical features in polycythemia
19. Therapeutic Recommendations for polycythemia vera
20. Blood volume in polycythemia as determined by labeled red cells
21. Measurement of total RBC volume relative to lean body mass for diagnosis of polycythemia
22. The diagnostic criteria of polycythemia rubra vera
23. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group
24. Diagnosing Polycythemia vera: A paradigm shift
25. Computer program for the diagnosis and treatment of polycythemia vera
26. Treatment of polycythemia vera with hydroxyurea
27. Recombinant interferon-α for treatment of polycythemia Vera
28. Acute leukemia after hydroxyurea therapy in polycythemia in polycythemia vera and allied disorders: Prospective study of the efficacy and leukemogenicity with therapeutic implications
29. Management of polycythemia vera with hydroxyurea
30. Low-dose aspirin in polycythemia vera: A pilot study
31. 32P between 1969 and 1981
32. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy
33. Outcome of 259 patients with primary proliferative polycythemia (PPP) and idiopathic thrombocythemia (IT) treated in a regional nuclear medicine department with phosphorus-32-a 15 year review
34. Treatment of polycythemia vera with radiophosphorus
35. Survival and risk of leukemia in polycythemia vera and essential thrombocythemia treated with oral radiophosphorus: Are safer drugs available
36. Polycythemia vera treated with pipobroman as single agent: Low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991)
37. Efficacy of pipobroman in the treatment of polycythmia vera: Long-term results in 163 patients
38. Treatment of polycythemia vera by radiophosphorus or busulphan: A randomized study
39. Treatment of primary proliferative polycythemia by venesection and low-dose busulphan. Retrospective study from one centre
40. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: A survey of American Society of Hematology members' practice patterns
41. Interferon alpha: Effects of long treatment with for polycythemia vera
42. Efficacy of recombinant interferon-α (rIFN-α) in polycythemia vera: A study of 17 patients and an analysis of published data
43. Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera
44. Allogeneic stem cell transplantation for myelofibrosis
45. Radioisotope investigations for the diagnosis and follow-up of polycythemic patients
46. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera